Home
EXAS
EXAS News

Latest Exact Sciences Corporation (EXAS) News on November 4, 2025

3 Unprofitable Stocks with Questionable Fundamentals

StockStory

5 days ago

3 Unprofitable Stocks with Questionable Fundamentals

TEM vs. EXAS: Which Genomics Player Offers Greater Upside?

Zacks

6 days ago

TEM vs. EXAS: Which Genomics Player Offers Greater Upside?

A Look at Exact Sciences’s Valuation as New Cancer Screening Advances Debut at Major Gastroenterology Meeting

Simply Wall St.

6 days ago

A Look at Exact Sciences’s Valuation as New Cancer Screening Advances Debut at Major Gastroenterology Meeting

Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

Zacks

6 days ago

Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

7 days ago

Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth

Avidity Biosciences (RNA) Moves 42.4% Higher: Will This Strength Last?

Zacks

7 days ago

Avidity Biosciences (RNA) Moves 42.4% Higher: Will This Strength Last?

3 Cash-Producing Stocks We Think Twice About

StockStory

7 days ago

3 Cash-Producing Stocks We Think Twice About

ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards?

Zacks

7 days ago

ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards?

5 Growth Stocks to Strengthen Your Portfolio in Q4 After a Fabulous Q3

Zacks

25 days ago

5 Growth Stocks to Strengthen Your Portfolio in Q4 After a Fabulous Q3

How Recent Developments Are Reshaping the Story for Exact Sciences

Simply Wall St.

a month ago

How Recent Developments Are Reshaping the Story for Exact Sciences

Here's Why Exact Sciences (EXAS) is a Strong Growth Stock

Zacks

a month ago

Here's Why Exact Sciences (EXAS) is a Strong Growth Stock

Exact Sciences (EXAS) Just Flashed Golden Cross Signal: Do You Buy?

Zacks

a month ago

Exact Sciences (EXAS) Just Flashed Golden Cross Signal: Do You Buy?

Why Exact Sciences (EXAS) is a Top Momentum Stock for the Long-Term

Zacks

a month ago

Why Exact Sciences (EXAS) is a Top Momentum Stock for the Long-Term

Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test

Business Wire

a month ago

Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test

Exact Sciences, Healthmine Partner to Boost Cologuard Screening Rates via Health Plan Incentives

Insider Monkey

a month ago

Exact Sciences, Healthmine Partner to Boost Cologuard Screening Rates via Health Plan Incentives

Healthmine and Exact Sciences Partner to Combine At-Home CRC Screening with Health Plan Incentives to Boost Preventive Care

Business Wire

2 months ago

Healthmine and Exact Sciences Partner to Combine At-Home CRC Screening with Health Plan Incentives to Boost Preventive Care

Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term

Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs

Zacks

2 months ago

Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs

Exact Sciences price target raised to $85 from $65 at Craig-Hallum

TipRanks

2 months ago

Exact Sciences price target raised to $85 from $65 at Craig-Hallum

More Blood Tests for Cancer Hit the Market

Barrons.com

2 months ago

More Blood Tests for Cancer Hit the Market

Exact Sciences And 2 Other Stocks Estimated To Be Trading Below Their Fair Value

Simply Wall St.

2 months ago

Exact Sciences And 2 Other Stocks Estimated To Be Trading Below Their Fair Value

Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run

Investor's Business Daily

2 months ago

Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run

Why Exact Sciences (EXAS) Stock Is Trading Up Today

StockStory

2 months ago

Why Exact Sciences (EXAS) Stock Is Trading Up Today

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

4 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

What's Fueling Tempus AI's Explosive Sales Growth?

Zacks

4 months ago

What's Fueling Tempus AI's Explosive Sales Growth?

Concerns Rise Over Exact Sciences Corp. (EXAS) Salesforce Reorganization Affecting Growth

Insider Monkey

4 months ago

Concerns Rise Over Exact Sciences Corp. (EXAS) Salesforce Reorganization Affecting Growth

Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care

Investor's Business Daily

4 months ago

Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care

The 5 Most Interesting Analyst Questions From Exact Sciences’s Q1 Earnings Call

StockStory

4 months ago

The 5 Most Interesting Analyst Questions From Exact Sciences’s Q1 Earnings Call

QGEN vs. EXAS: Which Stock Is the Better Value Option?

Zacks

4 months ago

QGEN vs. EXAS: Which Stock Is the Better Value Option?

Exact Sciences Expands Oncodetect Validation, Unveils MRD Innovation Roadmap.

Insider Monkey

4 months ago

Exact Sciences Expands Oncodetect Validation, Unveils MRD Innovation Roadmap.

Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks

StockStory

4 months ago

Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks

Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?

Zacks

4 months ago

Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

5 months ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Turn Down

StockStory

5 months ago

1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Turn Down

High Growth Tech Stocks In The US To Watch This June 2025

Simply Wall St.

5 months ago

High Growth Tech Stocks In The US To Watch This June 2025

CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue?

Zacks

5 months ago

CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue?

Should You Continue to Hold EXAS Sciences Stock in Your Portfolio?

Zacks

5 months ago

Should You Continue to Hold EXAS Sciences Stock in Your Portfolio?

Freenome posts pivotal liquid biopsy data as FDA filing nears completion

MedTech Dive

5 months ago

Freenome posts pivotal liquid biopsy data as FDA filing nears completion

3 Mid-Cap Stocks in the Doghouse

StockStory

5 months ago

3 Mid-Cap Stocks in the Doghouse

Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap

Business Wire

5 months ago

Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap

Exact Sciences to Participate in June Investor Conference

Business Wire

5 months ago

Exact Sciences to Participate in June Investor Conference

3 Low-Volatility Stocks Walking a Fine Line

StockStory

5 months ago

3 Low-Volatility Stocks Walking a Fine Line

Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025

Business Wire

5 months ago

Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025

Exact Sciences Corporation (EXAS) Slid on Fear of Competition

Insider Monkey

5 months ago

Exact Sciences Corporation (EXAS) Slid on Fear of Competition

Morningstar Research

5 months ago

Analyst Report: Exact Sciences Corporation

EXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin Expansion

StockStory

6 months ago

EXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin Expansion

1 Healthcare Stock Worth Investigating and 2 to Ignore

StockStory

6 months ago

1 Healthcare Stock Worth Investigating and 2 to Ignore

2 Brilliant Stocks to Buy With $200 and Hold for 5 Years

Motley Fool

6 months ago

2 Brilliant Stocks to Buy With $200 and Hold for 5 Years

Exact Sciences Earns 2025 Great Place To Work® Certification™

Business Wire

6 months ago

Exact Sciences Earns 2025 Great Place To Work® Certification™

What To Expect From Natera’s (NTRA) Q1 Earnings

StockStory

6 months ago

What To Expect From Natera’s (NTRA) Q1 Earnings

Morningstar Research

6 months ago

Analyst Report: Exact Sciences Corporation

Analysts Have Made A Financial Statement On Exact Sciences Corporation's (NASDAQ:EXAS) First-Quarter Report

Simply Wall St.

6 months ago

Analysts Have Made A Financial Statement On Exact Sciences Corporation's (NASDAQ:EXAS) First-Quarter Report

Exact Sciences First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

Exact Sciences First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Exact Sciences Corp Earnings Call

Exact Sciences (EXAS) Stock Trades Up, Here Is Why

StockStory

6 months ago

Exact Sciences (EXAS) Stock Trades Up, Here Is Why

MT Newswires

6 months ago

RBC Raises Price Target on Exact Sciences to $54 From $52, Keeps Sector Perform Rating

EXAS Stock Up on Q1 Earnings & Revenue Beat, 2025 Sales View Raised

Zacks

6 months ago

EXAS Stock Up on Q1 Earnings & Revenue Beat, 2025 Sales View Raised

Exact Sciences to Participate in May Investor Conference

Business Wire

6 months ago

Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp (EXAS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and New ...

GuruFocus.com

6 months ago

Exact Sciences Corp (EXAS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and New ...

Exact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock Soars

StockStory

6 months ago

Exact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock Soars

Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

Zacks

6 months ago

Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

Associated Press Finance

6 months ago

Exact Sciences: Q1 Earnings Snapshot

Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback.

Investor's Business Daily

6 months ago

Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

6 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Exact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of Earnings

StockStory

6 months ago

Exact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of Earnings

US High Growth Tech Stocks to Watch

Simply Wall St.

6 months ago

US High Growth Tech Stocks to Watch

Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025

Business Wire

6 months ago

Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025

Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?

Zacks

6 months ago

Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?

This Exact Sciences Insider Increased Their Holding In The Last Year

Simply Wall St.

6 months ago

This Exact Sciences Insider Increased Their Holding In The Last Year

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks

6 months ago

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Exact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential

Insider Monkey

6 months ago

Exact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential

2 Reasons to Like EXAS (and 1 Not So Much)

StockStory

6 months ago

2 Reasons to Like EXAS (and 1 Not So Much)

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Zacks

6 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test

Business Wire

6 months ago

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

Investor's Business Daily

7 months ago

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

StockStory

7 months ago

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

Tap Into the Silver Economy Boom With These Aging Demographics Stocks

Zacks

7 months ago

Tap Into the Silver Economy Boom With These Aging Demographics Stocks

JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups

Business Wire

7 months ago

JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

StockStory

7 months ago

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution

StockStory

7 months ago

2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution

MT Newswires

7 months ago

Mizuho Initiates Exact Sciences at Outperform With $60 Price Target

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

StockStory

7 months ago

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

Exact Sciences Schedules First Quarter 2025 Earnings Call

Business Wire

7 months ago

Exact Sciences Schedules First Quarter 2025 Earnings Call

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening

Business Wire

7 months ago

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening

High Growth Tech Stocks To Watch In The US March 2025

Simply Wall St.

7 months ago

High Growth Tech Stocks To Watch In The US March 2025

Should You Retain Exact Sciences Stock in Your Portfolio Now?

Zacks

7 months ago

Should You Retain Exact Sciences Stock in Your Portfolio Now?

2 Small-Cap Stocks on Our Watchlist and 1 to Ignore

StockStory

7 months ago

2 Small-Cap Stocks on Our Watchlist and 1 to Ignore

Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now

Insider Monkey

7 months ago

Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now

Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound?

Zacks

7 months ago

Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound?

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

StockStory

7 months ago

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

Should You Invest in Exact Sciences Corp. (EXAS)?

Insider Monkey

7 months ago

Should You Invest in Exact Sciences Corp. (EXAS)?

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

StockStory

7 months ago

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

PR Newswire

7 months ago

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

1 Stock Under $50 to Target This Week and 2 to Turn Down

StockStory

8 months ago

1 Stock Under $50 to Target This Week and 2 to Turn Down

MT Newswires

8 months ago

RBC Initiates Exact Sciences at Sector Perform With $52 Price Target

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner

Business Wire

8 months ago

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner

3 Top Cancer Biotechs to Keep An Eye On in 2025

Zacks

8 months ago

3 Top Cancer Biotechs to Keep An Eye On in 2025

Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS)

Insider Monkey

8 months ago

Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS)

Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now

Insider Monkey

8 months ago

Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.

8 months ago

Exploring Three High Growth Tech Stocks In The United States

Share on Social Networks: